Jeudi du PSCC #20: Liquid Biopsy
jeu. 24 sept.
|PSCC
Jeudi du PSCC


Heure et lieu
24 sept. 2026, 17:30 – 19:00
PSCC, The Hive 125 Rue Edouard Vaillant, 94800 Villejuif
À propos de l'événement
Don't miss the next "jeudi du PSCC" event on Liquid Biopsy.
Liquid biopsy is emerging as a major driver of personalized medicine in oncology, providing faster, less invasive, and more dynamic access to tumor-derived molecular information.
🎤We are pleased to welcome three outstanding speakers bringing complementary perspectives from research, industry and investment:
Pr Catherine Alix-Panabières, PhD, Full Professor of Oncology at the Faculty of Medicine of the University of Montpellier,
Alain Horvais, partner at Kurma Partners
Damien Magnée, co-founder and CEO of BioShare
Pr Catherine Alix-Panabières is an international pioneer in liquid biopsy and a University Professor and Clinical Oncologist at the University Hospital and the University of Montpellier. For more than 25 years, her work has made a decisive contribution to the development and clinical application of liquid biopsy, particularly through his research into circulating tumour cells (CTCs). Her research and leadership have played a major part in making liquid biopsy an indispensable tool in modern oncology.
Alain Horvais manages dedicated Diagnostic/Digital Health/HealthTech funds, KDx & KDx2 funds.
The funds are investing within Early innovative EU projects, either from academic teams or start up. He is Board Member of Deepull, NaoX, Poppins, Smartcatch, Axithra, and President of KDx Acceleration, the accelerator of KDx fund.
Damien Magnée is an international sales and business development leader specializing in molecular diagnostics and life sciences. He has extensive experience building global commercial networks, leading multicultural teams, and driving international market expansion. His expertise combines strategic leadership, partnership development, and the commercialization of innovative healthcare technologies.
This new edition of the “Jeudis du PSCC” will once again bring together key players from the oncology and biotech ecosystem for an insightful discussion at the crossroads of cutting-edge science and therapeutic innovation.
👉Registration link to come, stay tuned!
🏢🖥️On-site & online